Acute effects of cannabis on core and co-occurring features associated with autism spectrum disorder in adults.

Debra S Karhson, Emily M LaFrance, Carrie Cuttler

Abstract read

In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Debra S KarhsonDepartment of Psychology, University of New Orleans, New Orleans, LA, 70148, USA. dkarhson@uno.edu.

Emily M LaFranceDepartment of Psychology, Washington State University, P.O. Box 644820, Pullman, WA, 99164-4820, USA.

Carrie CuttlerDepartment of Psychology, Washington State University, P.O. Box 644820, Pullman, WA, 99164-4820, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacological interventions that treat core and co-occurring features of autism spectrum disorder (ASD) are a persistent unmet need. As such, use of cannabis to manage ASD features is common in the autistic community. Yet, few studies have examined the acute effects of cannabis on symptoms associated with ASD. Therefore, we measured changes in symptom ratings from before to after cannabis use in a sample of 111 self-identified autistic adults. Anonymized archival data sourced from the Strainprint

Indexed as

Autism Spectrum DisorderCannabisAdolescentAdultFemaleHumansMaleMiddle AgedSeverity of Illness IndexYoung AdultAutismCannabisMental controlRepetitive behaviorsSensory sensitivity

Identifiers

PMID41233406

DOI10.1038/s41598-025-23472-3

PMCPMC12615585

What Socratic holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.